Michael L. Pinn

2.7k total citations
32 papers, 2.2k citations indexed

About

Michael L. Pinn is a scholar working on Infectious Diseases, Molecular Biology and Surgery. According to data from OpenAlex, Michael L. Pinn has authored 32 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Michael L. Pinn's work include Tuberculosis Research and Epidemiology (17 papers), Cancer, Lipids, and Metabolism (7 papers) and Mycobacterium research and diagnosis (6 papers). Michael L. Pinn is often cited by papers focused on Tuberculosis Research and Epidemiology (17 papers), Cancer, Lipids, and Metabolism (7 papers) and Mycobacterium research and diagnosis (6 papers). Michael L. Pinn collaborates with scholars based in United States, Italy and France. Michael L. Pinn's co-authors include Francis P. Kuhajda, Jagan N. Thupari, Petros C. Karakousis, Jill M. McFadden, Craig A. Townsend, Gabriele V. Ronnett, Noton K. Dutta, Wan Fang Han, Eun Kyoung Kim and Susan M. Medghalchi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Michael L. Pinn

32 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Pinn United States 21 1.3k 867 462 372 355 32 2.2k
Yuhua Ji China 23 924 0.7× 318 0.4× 179 0.4× 120 0.3× 315 0.9× 78 1.7k
Neeru Saini India 28 1.8k 1.4× 1.1k 1.3× 62 0.1× 176 0.5× 207 0.6× 55 2.6k
Ho Tsoi Hong Kong 21 1.9k 1.5× 379 0.4× 349 0.8× 205 0.6× 208 0.6× 38 2.4k
David A. Rudnick United States 32 1.4k 1.1× 255 0.3× 127 0.3× 575 1.5× 755 2.1× 58 2.8k
Giuseppe Pizzorno United States 25 1.1k 0.8× 229 0.3× 93 0.2× 103 0.3× 165 0.5× 62 1.7k
Wei Tang United States 29 1.5k 1.2× 687 0.8× 72 0.2× 129 0.3× 255 0.7× 88 2.8k
Antonio F. Santidrián Spain 21 1.2k 0.9× 281 0.3× 90 0.2× 160 0.4× 274 0.8× 30 1.8k
Ju‐Gyeong Kang United States 19 2.2k 1.8× 1.0k 1.2× 61 0.1× 130 0.3× 206 0.6× 36 3.1k
Ke Jiang China 30 1.5k 1.2× 787 0.9× 131 0.3× 117 0.3× 406 1.1× 81 2.6k
Robert S. Kiss Canada 24 985 0.8× 221 0.3× 85 0.2× 852 2.3× 163 0.5× 51 2.3k

Countries citing papers authored by Michael L. Pinn

Since Specialization
Citations

This map shows the geographic impact of Michael L. Pinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Pinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Pinn more than expected).

Fields of papers citing papers by Michael L. Pinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Pinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Pinn. The network helps show where Michael L. Pinn may publish in the future.

Co-authorship network of co-authors of Michael L. Pinn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Pinn. A scholar is included among the top collaborators of Michael L. Pinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Pinn. Michael L. Pinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Yu-Min, Noton K. Dutta, James T. Gordy, et al.. (2020). Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination. Frontiers in Immunology. 11. 680–680. 10 indexed citations
2.
Chuang, Yu-Min, Liangmei He, Michael L. Pinn, et al.. (2020). Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis. Cellular and Molecular Immunology. 18(10). 2393–2401. 19 indexed citations
3.
Chuang, Yu-Min, Michael L. Pinn, Petros C. Karakousis, & Chien‐Fu Hung. (2018). Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice. Frontiers in Cellular and Infection Microbiology. 8. 31–31. 10 indexed citations
4.
Dutta, Noton K., Natalie Bruiners, Michael L. Pinn, et al.. (2016). Statin adjunctive therapy shortens the duration of TB treatment in mice. Journal of Antimicrobial Chemotherapy. 71(6). 1570–1577. 79 indexed citations
5.
Lanoix, Jean‐Philippe, Rokeya Tasneen, Paul E. O’Brien, et al.. (2016). High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 60(7). 4197–4205. 18 indexed citations
6.
Skerry, Ciaran, et al.. (2014). Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. Journal of Antimicrobial Chemotherapy. 69(9). 2453–2457. 90 indexed citations
7.
Dutta, Noton K., Michael L. Pinn, Ming Zhao, Michelle A. Rudek, & Petros C. Karakousis. (2013). Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis. Journal of Antimicrobial Chemotherapy. 68(6). 1327–1330. 16 indexed citations
8.
Dutta, Noton K., Peter B. Illei, Charles A. Peloquin, et al.. (2012). Rifapentine Is Not More Active than Rifampin against Chronic Tuberculosis in Guinea Pigs. Antimicrobial Agents and Chemotherapy. 56(7). 3726–3731. 24 indexed citations
9.
Ahmad, Zahoor, Mostafa Fraig, Michael L. Pinn, et al.. (2011). Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. Journal of Antimicrobial Chemotherapy. 66(7). 1560–1566. 19 indexed citations
10.
Ahmad, Zahoor, Eric Nuermberger, Rokeya Tasneen, et al.. (2010). Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. Journal of Antimicrobial Chemotherapy. 65(4). 729–734. 42 indexed citations
11.
Ahmad, Zahoor, Michael L. Pinn, Eric L. Nuermberger, et al.. (2010). The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters. Journal of Antimicrobial Chemotherapy. 65(10). 2172–2175. 9 indexed citations
12.
Ahmad, Zahoor, Lee G. Klinkenberg, Michael L. Pinn, et al.. (2009). Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug‐Tolerant, Not Drug‐Resistant,Mycobacterium tuberculosisin the Guinea Pig. The Journal of Infectious Diseases. 200(7). 1136–1143. 86 indexed citations
13.
Ahmad, Zahoor, et al.. (2009). A Guinea Pig Model of TB Chemotherapy.. A1679–A1679. 1 indexed citations
14.
McFadden, Jill M., Susan M. Medghalchi, Jagan N. Thupari, et al.. (2005). Application of a Flexible Synthesis of (5R)-Thiolactomycin To Develop New Inhibitors of Type I Fatty Acid Synthase. Journal of Medicinal Chemistry. 48(4). 946–961. 71 indexed citations
15.
Kim, Eun Kyoung, Ian Miller, Susan Aja, et al.. (2004). C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase. Journal of Biological Chemistry. 279(19). 19970–19976. 253 indexed citations
16.
Alli, Patricia M., Michael L. Pinn, Elizabeth M. Jaffee, Jill M. McFadden, & Francis P. Kuhajda. (2004). Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene. 24(1). 39–46. 136 indexed citations
17.
Thupari, Jagan N., Michael L. Pinn, & Francis P. Kuhajda. (2001). Fatty Acid Synthase Inhibition in Human Breast Cancer Cells Leads to Malonyl-CoA-Induced Inhibition of Fatty Acid Oxidation and Cytotoxicity. Biochemical and Biophysical Research Communications. 285(2). 217–223. 159 indexed citations
18.
Gabrielson, Edward, Michael L. Pinn, Joseph R. Testa, & Francis P. Kuhajda. (2001). Increased fatty acid synthase is a therapeutic target in mesothelioma.. PubMed. 7(1). 153–7. 90 indexed citations
19.
Brem, Henry, Rafael J. Tamargo, Alessandro Olivi, et al.. (1994). Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Journal of neurosurgery. 80(2). 283–290. 109 indexed citations
20.
Tamargo, Rafael J., Allen K. Sills, Carla S. Reinhard, et al.. (1991). Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema. Journal of neurosurgery. 74(6). 956–961. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuhua Ji Breakdown of academic impact, for papers by Neeru Saini Breakdown of academic impact, for papers by Ho Tsoi Breakdown of academic impact, for papers by David A. Rudnick Breakdown of academic impact, for papers by Giuseppe Pizzorno Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Antonio F. Santidrián Breakdown of academic impact, for papers by Ju‐Gyeong Kang Breakdown of academic impact, for papers by Ke Jiang Breakdown of academic impact, for papers by Robert S. Kiss
Rankless by CCL
2026